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Abstract 
Background: The effect of coronary artery bypass grafting on postoperative left 
ventricular function is still the subject of ongoing studies. The degree of recovery 
and its duration have not been precisely determined, and the published data are 
discordant. The objective of this study was to assess the effect of surgical 
revascularization on left ventricular systolic function. 
Methods: We prospectively studied 50 consecutive patients who underwent 
elective isolated coronary artery bypass grafting in the period from January 2017 to 
November 2017. All patients had echocardiography preoperatively, pre-discharge, 
and at 3 and 6 months postoperatively. Left ventricular end-systolic volume, left 
ventricular end-diastolic volume, stroke volume, and ejection fraction were 
measured in all patients.  
Results: The mean age was 57.22±7.04 years. The mean number of grafts was 
2.60±1.02. Improvement in Canadian Cardiovascular Society (CCS) score from (2.72 
± 1.03) preoperatively to [(0.12 ± 0.39), p<0.001] after six months was achieved. 
Additionally, improvement in the patient New York Heart Association (NYHA) score 
occurred from (1.70 ± 0.97) preoperatively to [(0.12 ± 0.33), p<0.001] after six 
months. A significant improvement in left ventricular function occurred as 
demonstrated by improvement in mean left ventricular ejection fraction from 
(54.14±9.80) % to [(62.40 ± 4.18) %, p<0.001] at six months. The mean total hospital 
stay was 5.62±1.51 days. The mean total intensive care unit length of stay was 
47.16±25.73 hours. Two patients (4%) had re-exploration for bleeding, and 
postoperative myocardial infarction occurred in three patients (6%).  One patient 
(2%) had postoperative neurocognitive dysfunction, and 3 patients (6%) had 
postoperative atrial fibrillation. Two patients (4%) suffered from superficial wound 
infection. There was no hospital mortality.   
Conclusion: Patients undergoing CABG experienced an improvement in left 
ventricular contractile function at six months postoperatively. Further studies are 
required to evaluate the changes after 6 months. 
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Introduction 
Long-term outcome of coronary artery bypass 
grafting (CABG) is excellent compare to coronary 
stenting, especially in patients with the distal left 
main disease, extensive multivessel disease and in 
patients with low ejection fraction and diabetes 
[1-5]. CABG has been shown to improve survival 
in the left main disease and in specific subgroups 
with a multivessel disease [5]. 
The myocardium may regain contractile 
function after revascularization if viable myocytes 
are present [6, 7]. However, the time course of 
recovery of contractile function after coronary 
artery bypass grafting is variable and mostly 
unknown. The studies investigating early 
postoperative changes have yielded conflicting 
results. Some have revealed contractile 
improvement intraoperatively or within the first 
weeks postoperatively [7, 8], while other studies 
have detected no change [9, 10] or even 
deterioration of function [11].  
The aim of this study was to assess the effect 
of coronary artery bypass grafting on left 
ventricular systolic function. 
Patients and Methods: 
The study population consisted of 50 patients 
who were prospectively scheduled for elective 
isolated CABG between January and November 
2017. The participants signed informed consent 
after receiving full information about the study 
design. Patients with liver or renal disease, 
diabetes mellitus, and re-operative CABG were 
excluded from the study. All patients in this study 
had a full comprehensive clinical history.  
Complete clinical general and cardiac 
examination was performed for all patients to 
detect signs of heart failure, arrhythmias, and 
associated risk factors. Laboratory investigations, 
plain chest X-ray, 12 lead electrocardiography 
(ECG) were performed for every patient 
preoperatively.  
Two-dimensional echocardiography was 
completed within one month of the indexed 
operation with a SONOS 4500 machine (Philips 
Technologies, Andover, Massachusetts, USA), 
equipped with a 2.5-MHz transducer. 
Preoperative carotid duplex and coronary 
angiography were performed in all patients. CABG 
using left internal mammary artery (LIMA) and 
saphenous vein grafts (SVG) was performed to all 
patients with a standard incision and closure 
technique. Fine monofilament polypropylene 
sutures (8/0 or 7/0) were used for all distal 
anastomoses. Proximal anastomoses were 
performed with fine monofilament polypropylene 
suture (6/0).  
Cardiopulmonary bypass was conducted using 
a membrane oxygenator and a non-pulsatile flow 
of 2.2-2.5 liters/min/ m2 body surface area. 
Myocardial protection was through repeated 
infusions of antegrade warm blood cardioplegia 
solution every 15:20 minutes containing 
potassium chloride 0.3 mEq/kg over three minutes 
as initial dose and then half the dose over 90 
seconds every 20 minutes.  
Time of aortic cross-clamp, extracorporeal 
circulation, operative time, number of grafts, 
inotropic support, and need for intra-aortic 
balloon pump (IABP) were recorded. Entire 
intensive care unit (ICU) stay was recorded, and 
ICU events including dose and duration of 
inotropic support, use of intra-aortic balloon 
pump (IABP), perioperative myocardial infarction 
(MI) diagnosed with new ECG changes plus 
elevated cardiac enzymes with or without 
hemodynamic instability, arrhythmias, and 
postoperative bleeding. The total hospital stay 
was recorded. Postoperative echocardiography 
with the estimation of ESV, EDV, SV, and EF was 
done for all patients within one week after 
surgery, three months, and after six months 
postoperatively. The Research Ethics Committee 
approved the study. 
Statistical Analysis 
Data were collected, tabulated, and 
statistically analyzed using an IBM compatible 
personal computer with SPSS statistical package 
version 20 (SPSS Inc. released 2011. IBM SPSS 
statistics for windows, version 20.0, Armonk, NY: 
IBM Corp.). Quantitative data were summarized as 
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Table 1: Clinical characteristics and angiographic data. 
(Continuous data are presented as mean and standard 
deviation and categorical data as number and percent) 
Parameters N= 50 
Age (mean ± SD; years) 57.22 ± 7.04 
BMI (mean ± SD; kg/m2) 30.62 ± 3.81 
Male gender [n (%)]  
Female gender [n (%)] 
44 (88) 
6 (12) 
Previous MI [n (%)]  31 (62) 
Hypertension [n (%)]       
Hyperlipidemia 
25 (50) 
19 (38) 
Smoking 
Current smokers 
    Former smokers 
    Non smokers 
14 (28) 
14 (28) 
22 (44) 
Coronary angiography [n (%)] 
One-vessel disease  2 (04) 
Two-vessel disease  9 (18) 
Multivessel disease 32 (64) 
Left main disease 7 (14) 
NYHA class [n (%)] 
No     5 (10) 
I 17 (34) 
II 17 (34) 
III 10 (20) 
IV 1 (02) 
CCS class [n (%)] 
No    3 (06) 
I    2 (04) 
II    11 (22) 
III     24 (48) 
IV       10 (20) 
LVEF [n (%)] 
≥50    30 (60) 
<50     20 (40) 
EuroSCORE II [n (%)] 
0–1      44 (88) 
1–2        5 (10) 
2-3        1 (02) 
BMI: Body mass index; MI: myocardial infarction; 
NYHA: New York Heart Association; CCS: Canadian 
Cardiovascular Society; EuroSCORE II: European 
System for Cardiac Operative Risk Evaluation; LVEF: 
left ventricular ejection fraction. 
mean ± standard deviation (SD), while qualitative 
data were described using number and percent. 
The Kolmogorov-Smirnov test was used to verify 
the normality of distribution. ANOVA with 
repeated measures was used for normally 
distributed quantitative variables to compare 
between more than two periods or stages, and 
Post Hoc test (Bonferroni adjusted) for pairwise 
comparisons. Friedman test was used for 
abnormally distributed quantitative variables to 
compare between more than two periods or 
stages and Post Hoc test (Dunn-Bonferroni) for 
pairwise comparisons. A p-value of less than 0.05 
was always used to indicate significance.  
Results 
This study included 50 (44 male and 6 female) 
patients who underwent isolated CABG. Their 
mean age was 57.22±7.04 years (range between 
35 and 69 years). Preoperative echocardiographic 
data showed mean end-systolic volume index 
(ESVI) (27.63±9.66 ml/m2), mean end-diastolic 
volume index (EDVI) (60.26±11.17 ml/m2), mean 
stroke volume (SV) (64.86±11.95 ml), and mean 
ejection fraction (EF) (54.14±9.80) %.  Baseline 
clinical characteristics and angiographic data of 
the study population are presented in Table 1. 
The mean total bypass time was 90.56±32.22 
minutes. Inotropic support was used in 28 patients 
(56%) with a mean duration of 14.32±18.72 hours. 
Of those patients who required inotropic support, 
there were 14 patients admitted to surgery with 
low preoperative EF (<50%), and 6 patients had 
incomplete revascularization due to the surgeon's 
inability to graft tiny and diffusely diseased 
coronary arteries. Intra-aortic balloon pump was 
used in one patient only (2%) who had a low 
preoperative EF (38%) and was incompletely 
revascularized (Table 2). 
Table 2: Operative data (Continuous data are 
presented as mean and standard deviation and 
categorical data as number and percent) 
Operative data No. = 50 
Mean cross clamp time (min)  51.80±19.90 
Mean total bypass time (min)  90.56±32.22  
Mean total operative time (min)   261.0±261.0 
Total number of grafts   133(2.60±1.02) 
DC shocks       4(8%) 
Incomplete revascularization 8(16%) 
IABP      1(2%) 
Inotropic support  28(56%) 
IABP: intra-aortic balloon pump 
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Table 3: Postoperative data. (Continuous data are 
presented as mean and standard deviation and 
categorical data as number and percent) 
Postoperative Data 
Total ICU stay (hr)  47.16±25.73 
Total hospital stay (days)  5.62±1.51 
Ventilation hours (hr)  6.56±3.98 
Inotropic support n (%)  28 (56%) 
Inotropic support duration (hr) 14.32±18.17 
Peri-operative MI n (%)  3 (6%)   
Reopening for bleeding      2 (4%) 
Neurocognitive dysfunction        1 (2%) 
Atrial fibrillation        3 (6%) 
Superficial wound infection      2 (4%) 
MI: myocardial infarction 
The mean ICU stay was 47.16±25.73 hours. No 
mortality was recorded during the study period. 
Postoperative myocardial infarction occurred in 3 
patients (6%). Of those who developed 
postoperative MI, one patient was admitted with 
low preoperative EF (38%), incompletely 
revascularized, and required insertion of IABP. The 
second patient needed LAD endarterectomy and 
was completely revascularized with five grafts and 
prolonged cross-clamp time (125 minutes) and 
total bypass time (205 minutes). The third patient 
developed MI with no apparent reason to us but 
may be due to venous graft occlusion or native 
coronary artery diffuse disease. Postoperative 
atrial fibrillation recorded in three patients (6%) of 
whom 2 patients had a low preoperative EF, and 
the three patients were nonsmokers. One case 
recovered with agitation. Two cases were 
reopened for bleeding postoperatively. Two cases 
had a superficial wound infection (Table 3). 
Improvement of preoperative patient 
symptoms was observed postoperatively with 
improvement in Canadian Cardiovascular Society 
(CCS) score from (2.72 ± 1.03) preoperatively to 
[(0.16 ± 0.42), p<0.0001] after three months, and 
then to [(0.12 ± 0.39), p<0.001] after six months 
(Table 4). 
Postoperative echocardiography (pre-hospital 
discharge) showed mean ESVI [(26.67 ± 6.49 
ml/m2), p=1.000], mean EDVI [(59.11 ± 9.26 
ml/m2), p=1.000], mean SV [(64.60 ± 8.81 ml.), 
p=1.000], and mean EF [(54.64 ± 5.76) %, p=1.000]. 
Echocardiography 3 months after operation 
showed mean ESVI [(23.01 ± 4.57 ml/m2), p<.001], 
mean EDVI [(56.78 ± 7.84 ml/m2), p=0.137], mean 
SV [(69.08 ± 6.97 ml), p=0.023], and mean EF 
[(60.12 ± 4.64) %, p<0.001]. Echocardiography 
after 6 months showed mean ESVI [(21.07 ± 4.10 
ml/m2), p<0.001], mean EDVI [(56.76 ± 6.77 
ml/m2), p=0.009], mean SV [(71.74 ± 5.97 ml), 
p<0.001], and mean EF [(62.40 ± 4.18) %, p<0.001]. 
Preoperative and postoperative echo-
cardiographic measurements in the study 
population as a whole are presented in (Table 5). 
Discussion 
Studies assessing the changes in left 
ventricular systolic function after CABG are scarce. 
We evaluated the pre- and postoperative 
echocardiography in patients undergoing CABG 
with normal or reduced preoperative ejection 
fraction. In the present study, there was a 
significant difference in NYHA functional 
classification as it is decreased from (1.70±0.97) 
preoperatively to (0.12±0.33) at six months. 
Eleven (22%) patients were complaining of 
dyspnea NYHA III/IV preoperatively.  After CABG, 
improvement in heart failure symptoms was 
observed in the study population, with only 6 
(12%) patients had dyspnea (NYHA I). These 
results come in agreement with others [12, 13] 
who found a correlation between the clinical and 
echocardiographic, and the extent of preoperative 
myocardial viability. Furthermore, Marwick and 
collaborators [14] found an association between 
exercise capacity and degree of jeopardized tissue 
diagnosed with positron emission tomography. 
Table 4: Changes in CCS and NYHA (Data are presented as mean and standard deviation) 
Variables PRE After 3 months After 6 months p-value 
CCS 2.72±1.0 0.16±0.42 0.12±0.39 <0.001 
NYHA 1.70±0.9 0.38±0.60 0.12±0.33 <0.001 
NYHA: New York Heart Association; CCS: Canadian Cardiovascular Society 
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Table 5: Echocardiographic measurements before and after CABG. (Data are presented as mean and standard 
deviation.) 
Variables 
All patients (n=50) 
p-value 
Pre-CABG One-week Post-CABG After 3 months After 6 months 
LVEF (%) 54.14±9.80  54.64±5.76 60.12±4.64 62.40±4.18 <0.001 
ESVI (ml/m2) 27.63±9.66  26.67±6.49 23.01±4.57 21.07±4.10 <0.001 
EDVI (ml/m2) 60.26±11.17  59.11±9.26 56.78±7.84 56.76±6.77 0.009 
SV (ml)     64.86±11. 95    64.60±8.81 69.08±6.97 71.74±5.97 <0.001 
LVEF: left ventricular ejection fraction; ESVI: end-systolic volume index: EDVI: end-diastolic volume index; 
SV: stroke volume. 
Several studies [15, 16] showed that 
successful revascularization of viable myocardial 
tissue with CABG might restore myocardial 
perfusion, improve left ventricular function, and 
alleviate anginal complaints. In the present study, 
the Canadian Cardiovascular Society (CCS) 
classification of angina improved significantly 
from (2.72 ± 1.03) to (0.12 ± 0.39) at six months. 
The results were in agreement with Peric and 
colleagues [17] that showed that the CCS angina 
class improved after CABG. Additionally, we 
confirmed previous findings in the literature [18, 
19] that after CABG, the vast majority of the
patients have less or no angina. The question of 
whether revascularization can alleviate symptoms 
in these patients, which are usually their primary 
functional limitation, remains a paramount 
concern both for patients and surgeons. We 
observed a marked improvement of anginal 
symptoms and reduction of anti-anginal 
medications postoperatively.  
From a hemodynamic point of view, a 
significant improvement in overall left ventricular 
systolic function occurred in the whole cohort of 
the patients as demonstrated by decrease in 
mean ESVI from (27.63 ± 9.66 ml/m2) 
preoperatively to (23.01 ± 4.57 ml/m2) at three 
months, and then to (21.07 ± 4.10 ml/m2) at six 
months. Moreover, a decrease in mean EDVI 
from (60.26 ± 11.17 ml/m2) preoperatively to 
(56.78 ± 7.84 ml/m2) occurred at three months 
postoperatively, and then to (56.76 ± 6.77 ml/
m2) at six months postoperatively. Increase in 
mean SV from (64.86 ± 11.95 ml) preoperatively 
to (69.08 ± 6.97 ml) occurred at three months 
and then to (71.74 ± 5.97 ml) at six months 
postoperatively. The mean EF significantly 
increased from (54.14 ± 9.8) 
% preoperatively to (60.12±4.64) % at three 
months, and then to (62.40±4.18) % at six months. 
In our cohort, the maximum improvement in LV 
contractility parameters was observed after 6 
months. A similar time of systolic function 
recovery after revascularization was noted by 
others [20-21]. On the other hand, Rizzello and 
colleagues [22] observed the improvement in 
NYHA and CCS class after 9 to 12 months from the 
intervention. 
In view of these data, Bax [6] emphasized that 
the choice of the optimum contractility 
assessment period after CABG remains unclear. 
Literature data suggested that cardiomyocyte 
function recovery may be expected between 6 
and 12 months after the intervention [12, 23], or 
sometimes after a more extended period of up to 
4 years [24]. In essence, the functional recovery 
of the impaired ventricular function depends on 
the restoration of effective contractile 
myocardium though it may take a different time 
period depending on some crucial factors, such as 
the duration of hypoperfusion, degree of 
ventricular remodeling, etc. As long as there is 
enough viable myocardium in the impaired 
ventricle, there is the possibility of the 
improvement or recovery in systolic function with 
the restoration of blood supply.  
An increase in left ventricular ejection fraction 
after coronary revascularization is generally 
thought to be due to hibernation [25, 26], and 
stunning has also been suggested as an 
explanation [27]. We observed significantly 
improved LVEF values in 58% of all our patients. 
This suggests a mixture of hibernation and chronic 
or repetitive stunning. This should be seen in the 
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light of the fact that 60% of all patients had normal 
LVEF before surgery. The mechanism and 
underlying pathophysiology are not evident, but 
the simple clinical consequence is that in a patient 
population like the present one— patients 
referred for CABG mainly because of angina 
combined with a lack of technical possibility for 
PCI and with a rather low European System for 
Cardiac Operative Risk Evaluation (EuroSCORE II), 
chances of improved left ventricular function are 
significant and independent of the kind of 
perfusion defects. Patients with non-viable 
myocardium will show little or no improvement of 
LV function after the restoration of the blood flow. 
In patients with borderline perfusion defects, 
revascularization may lead to partial 
improvement, and the viability study will 
determine the fate of the irreversible part of the 
defect. 
Study limitations 
There are several limitations to our study. 
There are no preoperative viability studies to all 
patients; however, routine viability studies were 
not indicated in all patients without 
echocardiographic data suggestive of non-viable 
myocardium. Our sample size is limited; however, 
we were able to detect the improvement of left 
ventricular function in our patients. Finally, 
coronary angiography was not repeated 
postoperatively to verify graft patency; routine 
coronary angiography is not the standard of care. 
Conclusion 
Patients undergoing CABG experience an 
improvement in left ventricular contractile 
function within six months of the operation as 
detected with echocardiography.  Further 
improvement in left ventricular contractile 
function may occur after six months post CABG 
that needs further studies. 
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